LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

Accueil・Liste d'Actions・Becton Dickinson and Co

Becton Dickinson and Co

Fermé

Secteur Soins de santé

240.31 -1.34

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

239.9

Max

243.57

Chiffres clés
By Trading Economics
Revenu	-50M 487M
Ventes	10M 5.1B
P/E Moyenne du Secteur	50.04 112.16
BPA	3.5
Marge bénéficiaire	9.625
EBITDA	-124M 1.2B

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+15.62 upside

Dividendes
By Dow Jones
Prochains Résultats	7 nov. 2024
Date du Prochain Dividende	27 déc. 2024
Date du Prochain Détachement de Dividende	5 déc. 2024

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-150M 69B
Ouverture précédente	241.65
Clôture précédente	240.31

Sentiment de l'Actualité

By Acuity

95%

4 / 366 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bullish Evidence

235.4 / 244.5 Support & Résistance

Becton Dickinson and Co Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

1 août 2024, 11:08 UTC

Résultats

Becton 3Q Adjusted Earnings Top Views But International Sales Weigh on FY24 Outlook

3 juin 2024, 11:18 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash

2 mai 2024, 11:07 UTC

Résultats

Becton Dickinson Shakes Up 2024 Outlook After Growing 2Q Sales, Earnings

1 août 2024, 10:37 UTC

Résultats

Becton Dickinson Now Sees FY24 Revenue About $20.1B; Had Seen $20.1B-$20.3B >BDX

1 août 2024, 10:35 UTC

Résultats

Becton Dickinson Sees FY24 Revenue Up About 3.7%, Organic Revenue Up 5%-5.25% >BDX

1 août 2024, 10:35 UTC

Résultats

Becton Dickinson Sees FY24 Adj EPS $13.05-Adj EPS $13.15 >BDX

1 août 2024, 10:30 UTC

Résultats

Becton Dickinson 3Q EPS $1.68 >BDX

1 août 2024, 10:30 UTC

Résultats

Becton Dickinson 3Q Net $487M >BDX

1 août 2024, 10:30 UTC

Résultats

Becton Dickinson 3Q Adj EPS $3.50 >BDX

1 août 2024, 10:30 UTC

Résultats

Becton Dickinson 3Q Rev $5B >BDX

4 juin 2024, 17:26 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3 juin 2024, 15:30 UTC

Actions en Tendance

Stocks to Watch Monday: GameStop, AMC, Paramount, Nvidia -- WSJ

3 juin 2024, 13:26 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3 juin 2024, 12:25 UTC

Actualités

Acquisitions, Fusions, Rachats

Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- Update

3 juin 2024, 11:03 UTC

Actualités

Acquisitions, Fusions, Rachats

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash

3 juin 2024, 10:40 UTC

Acquisitions, Fusions, Rachats

Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch

3 juin 2024, 10:32 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson: Acquired Business Has About 4,500 Employees >BDX EW

3 juin 2024, 10:31 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson: Acquired Business Generated More Than $900 Million Revenue in 2023 >BDX

3 juin 2024, 10:31 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson: Deal Expands Portfolio of Smart Connected Care Solutions >BDX EW

3 juin 2024, 10:30 UTC

Acquisitions, Fusions, Rachats

Becton Dickinson to Buy Edwards Lifesciences Critical Care Product Group for $4.2 Billion >BDX EW

3 juin 2024, 10:30 UTC

Acquisitions, Fusions, Rachats

BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW

2 mai 2024, 10:35 UTC

Résultats

Becton Dickinson Had Seen FY24 Adjusted EPS $12.82-$13.06 >BDX

2 mai 2024, 10:34 UTC

Résultats

Becton Dickinson Raises FY24 View To Adj EPS $12.95-Adj EPS $13.15 >BDX

2 mai 2024, 10:34 UTC

Résultats

Becton Dickinson Still Sees FY24 Organic Revenue Growth of 5.5%-6.25% >BDX

2 mai 2024, 10:33 UTC

Résultats

Becton Dickinson Had Seen FY24 Revenue $20.2B-$20.4B >BDX

2 mai 2024, 10:33 UTC

Résultats

Becton Dickinson Cuts FY24 View To Rev $20.1B-$20.3B >BDX

2 mai 2024, 10:30 UTC

Résultats

Becton Dickinson 2Q Net $537M >BDX

2 mai 2024, 10:30 UTC

Résultats

Becton Dickinson 2Q Adj EPS $3.17 >BDX

2 mai 2024, 10:30 UTC

Résultats

Becton Dickinson 2Q EPS $1.85 >BDX

2 mai 2024, 10:30 UTC

Résultats

Becton Dickinson 2Q Rev $5B >BDX

Comparaison

Variation de prix

Becton Dickinson and Co prévision

Objectif de Prix

By TipRanks

15.62% hausse

Prévisions sur 12 Mois

Moyen 281.83 USD 15.62%

Haut 312 USD

Bas 260 USD

Basé sur 12 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

12 ratings

Achat

Maintien

Vente

Basé sur 12 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

235.4 / 244.5Support & Résistance

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

4 / 366Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Becton Dickinson and Co

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.